SCHEMBL1090872

SCHEMBL1090872

O=C(CCc1ccccc1)N1CCC(N2CCCC(Nc3nccc(N4CCCCCC4)n3)C2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.56
GRIN2B Q13224 1/20 0.48
ALDH1A1 P00352 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
MAPT P10636 1/20 0.47
L3MBTL3 Q96JM7 1/20 0.44
KDM4E B2RXH2 1/20 0.43
MAPK1 P28482 1/20 0.43
ME2 P23368 1/20 0.43
ME1 P48163 1/20 0.43
ME3 Q16798 1/20 0.43
NPC1 O15118 1/20 0.43
CCNK O75909 1/20 0.42
CDK12 Q9NYV4 1/20 0.42
OGA O60502 1/20 0.42
MRGPRX1 Q96LB2 1/20 0.42
KDM4A O75164 1/20 0.42
KDM5C P41229 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
KDM2A Q9Y2K7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090514 0.98 CXCR4 (0.56) CXCR4GRIN2BALDH1A1TDP1MAPT
SCHEMBL1090425 0.96 CXCR4 (0.59) CXCR4GRIN2BALDH1A1TDP1MAPT
SCHEMBL1090766 0.93 CXCR4 (0.55) CXCR4GRIN2BALDH1A1TDP1KDM4E
SCHEMBL1090634 0.92 CXCR4 (0.54) CXCR4GRIN2BALDH1A1TDP1KDM4E
SCHEMBL1091169 0.92 CXCR4 (0.58) CXCR4ALDH1A1KDM4EME2ME1
SCHEMBL1090824 0.90 CXCR4 (0.58) CXCR4ALDH1A1KDM4EME2ME1
SCHEMBL1090337 0.89 CXCR4 (0.57) CXCR4GRIN2BALDH1A1TDP1KDM4E
SCHEMBL1089688 0.89 CXCR4 (0.56) CXCR4ALDH1A1MAPTKDM4ENPC1
SCHEMBL1091304 0.88 CCNK (0.48) CXCR4CCNKCDK12MRGPRX1HRH4
SCHEMBL1089338 0.88 CXCR4 (0.54) CXCR4CCNKCDK12HRH4IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885GRIN2B 1616/4885ALDH1A1 916/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885GRIN2B 1616/4885ALDH1A1 916/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885GRIN2B 1616/4885ALDH1A1 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.